Skip to main content
. 2022 Jul 4;12:62. doi: 10.1186/s13613-022-01040-6

Table 1.

Outcomes

Outcome All patients
(n = 1834)
Primary outcome
 Major adverse kidney events within 30 days 519/1834 (28.3%)
Components of primary outcome
 Death within 30 days 417/1834 (22.7%)
 Renal replacement therapy 128/1834 (7.0%)
 Among survivors 85/1417 (6.0%)
 Among non-survivors 43/417 (10.3%)
 Last inpatient plasma creatinine level ≥ 200% of baseline without renal replacement therapy 38/1834 (2.1%)
 Among survivors 17/1417 (1.2%)
 Among non-survivors 21/417 (5.0%)

Values are n (%)